MICROBIOME HEALTH RESEARCH INSTITUTE INC

EIN: 461681862 501(c)(3) Medical Research

WOBURN, MA

Total Revenue
$4,376,048
Total Expenses
$3,509,776
Total Assets
$9,964,560
Net Assets
$8,732,524
🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Sign In — Free (10 views/day)

Financial Trends

Organization Details

Formation Year
2013
Legal Domicile
MA
Principal Officer
JULIE BARRETT O'BRIEN
Phone
6175752201
Tax Period
2023-01-01 to 2023-12-31

MICROBIOME HEALTH RESEARCH INSTITUTE INC, founded in 2013, is a community nonprofit in the Medical Research sector that reported $4.4M in total revenue in fiscal year 2023. Revenue surged 107% from the prior year, signaling strong growth momentum. The organization ran a surplus of $866K, a strong 20% operating margin.

Mission

OPENBIOME IS A PIONEERING NONPROFIT THAT ACCELERATES BOLD DISCOVERIES IN MICROBIOME SCIENCE, ETHICALLY AND EQUITABLY, TO IMPROVE HEALTH FOR ALL.

Program Service Accomplishments

Program 1
Expenses: $1,390,228 Revenue: $3,233,441

ALIGNED WITH CURRENT FDA POLICY, OPENBIOME REMAINS COMMITTED TO ENSURING THAT ALL PATIENTS SUFFERING FROM C. DIFFICILE INFECTION CONTINUE TO HAVE SAFE, CONVENIENT, AND AFFORDABLE ACCESS TO FECAL...

Read more

ALIGNED WITH CURRENT FDA POLICY, OPENBIOME REMAINS COMMITTED TO ENSURING THAT ALL PATIENTS SUFFERING FROM C. DIFFICILE INFECTION CONTINUE TO HAVE SAFE, CONVENIENT, AND AFFORDABLE ACCESS TO FECAL MICROBIOTA TRANSPLANTATION (FMT) THROUGH THEIR PHYSICIAN. IN OUR COLLABORATION WITH THE UNIVERSITY OF MINNESOTA (UMN), UNDER AN ACTIVE INVESTIGATIONAL DRUG APPLICATION (IND), WE CONTINUE TO DISTRIBUTE FMT TO OUR CLINICAL NETWORK AND ARE WORKING WITH FDA TO ENSURE THAT ALL REGULATORY FILINGS ARE KEPT CURRENT AND COMPLIANT WITH THE EXISTING POLICY AND GUIDANCE. WE STRIVE TO MAKE THE PATH TO TREATMENT AS SIMPLE AS POSSIBLE FOR PATIENTS AND THEIR DOCTORS, WHILE BRINGING A LEVEL OF SAFETY AND STANDARDIZATION TO THE PROCESS THAT HAS SET THE STANDARD FOR THIS EMERGING FIELD. OPENBIOME PROVIDES FMT THAT HAS BEEN MANUFACTURED BY UMN AND HAS BEEN RIGOROUSLY SCREENED. THESE READY-TO-USE FECAL MICROBIOTA PREPARATIONS ALLOW PHYSICIANS TO DEVOTE THEIR TIME AND ENERGY TO TREATING PATIENTS, RATHER THAN THE COMPLEXITIES OF MANAGING A STOOL DONOR PROGRAM.

Program 2
Expenses: $39,484 Revenue: $22,100

CLINICAL RESEARCH PROGRAM: OPENBIOME SEEKS TO ENABLE TRANSLATIONAL RESEARCH ON THE HUMAN MICROBIOME. TO DO SO, WE PROVIDE A SUITE OF SERVICES TO HELP INVESTIGATORS UNCOVER THE ROLE OF THE GUT...

Read more

CLINICAL RESEARCH PROGRAM: OPENBIOME SEEKS TO ENABLE TRANSLATIONAL RESEARCH ON THE HUMAN MICROBIOME. TO DO SO, WE PROVIDE A SUITE OF SERVICES TO HELP INVESTIGATORS UNCOVER THE ROLE OF THE GUT MICROBIOME IN HUMAN HEALTH, AND TO DISCOVER HOW ENGINEERING IT CAN DRIVE BETTER HEALTH OUTCOMES. OUR SERVICES INCLUDE THE PROVISION OF CUSTOMIZED FECAL MICROBIOTA PREPARATIONS, STUDY DESIGN AND REGULATORY SUPPORT FOR CLINICAL TRIALS, AND BIOINFORMATICS AND ANALYTICAL SERVICES. OPENBIOME ALSO SPONSORS ITS OWN STUDIES INVESTIGATING CRITICAL MICROBIOME-RELATED HEALTH CONDITIONS.

Program 3
Expenses: $897,620 Revenue: $25,699

THE GLOBAL MICROBIOME CONSERVANCY (GMBC) PROGRAM AT OPENBIOME PARTNERS WITH SCIENTISTS AROUND THE WORLD TO CONSERVE, STUDY, AND SHARE UNDERREPRESENTED AND AT-RISK HUMAN MICROBIOME DIVERSITY. THE GMBC...

Read more

THE GLOBAL MICROBIOME CONSERVANCY (GMBC) PROGRAM AT OPENBIOME PARTNERS WITH SCIENTISTS AROUND THE WORLD TO CONSERVE, STUDY, AND SHARE UNDERREPRESENTED AND AT-RISK HUMAN MICROBIOME DIVERSITY. THE GMBC HAS ESTABLISHED A NETWORK OF 80+ RESEARCHERS IN OVER THREE DOZEN COUNTRIES AND BUILT A DIVERSE COLLECTION OF SAMPLES AND BACTERIAL ISOLATES TO SPARK SCIENTIFIC DISCOVERY AND ENABLE NEW SOLUTIONS TO MICROBIOME-ASSOCIATED DISEASE.THE GMBC WAS ESTABLISHED TO SOLVE THE URGENT NEED FOR A DEEPER, MORE GLOBALLY REPRESENTATIVE UNDERSTANDING OF THE HUMAN MICROBIOME THAT ADDRESSES THE HEALTH CONCERNS OF ALL. A DEEPER UNDERSTANDING OF THE HUMAN MICROBIOME IS CRITICAL TO SOLVING GLOBAL HEALTH CHALLENGES SUCH AS ANTIMICROBIAL RESISTANCE, MALNUTRITION, DEPRESSION, AS WELL AS AUTOIMMUNE AND METABOLIC DISORDERS THAT ARE LINKED TO THE COMMUNITIES OF BACTERIA THAT LIVE WITHIN US. HOWEVER, OUR CURRENT BODY OF KNOWLEDGE, LARGELY BASED ON U.S. AND EUROPEAN POPULATIONS, IS BIASED AND VASTLY INCOMPLETE. AS INDUSTRIALIZATION DISRUPTS HUMAN MICROBIOME DIVERSITY ON A GLOBAL SCALE, THE WINDOW OF OPPORTUNITY TO STUDY AND APPLY THE FULL POTENTIAL OF THE HUMAN MICROBIOME IS CLOSING.TO RADICALLY EXPAND SCIENTISTS' VIEW OF THE MICROBIOME, THE GMBC PROGRAM HAS BUILT A GLOBALLY REPRESENTATIVE COLLECTION OF HUMAN MICROBIOME SAMPLES, BACTERIAL ISOLATES, AND ASSOCIATED METADATA AS A RESOURCE FOR THE RESEARCH COMMUNITY. WORKING WITH LOCAL SCIENTISTS AROUND THE WORLD, WE COLLECT AND CONSERVE MICROBIOME SAMPLES (PRIMARILY GUT, BUT ALSO MOUTH, SKIN AND OTHER BODY SITES) FROM PARTICIPATING COMMUNITIES. THESE SAMPLES ARE THEN CHARACTERIZED AND, FROM THEM, THE GMBC GENERATES BACTERIAL ISOLATES. RESULTING RESEARCH MATERIALS AND ASSOCIATED DATA ARE SHARED THROUGH THE GMBC COLLECTIONTHE MOST GLOBALLY REPRESENTATIVE COLLECTION OF ITS KIND THAT PROVIDES SCIENTISTS ACCESS TO PREVIOUSLY UNAVAILABLE BIODIVERSITY.IN NOVEMBER 2023, OPENBIOME BEGAN THE TRANSFER OF THE GLOBAL MICROBIOME CONSERVANCY PROGRAM TO KIEL UNIVERSITY. OPENBIOME REMAINS A FUNDER OF THE PROGRAM AND AGREED TO DISTRIBUTE A MAXIMUM OF FOUR (4) GRANTS UP TO $50,000 EACH TO IN-COUNTRY COLLABORATORS IN THE 2024 COLLECTION PIPELINE.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Sign In — Free (10 views/day)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $785,396
Program Service Revenue $22,100
Investment Income $309,412
Other Revenue $3,259,140
TOTAL REVENUE $4,376,048

Expense Breakdown

Grants Paid $0
Salaries & Benefits $2,320,669
Fundraising Expenses $0
Program Expenses $2,327,332
Other Expenses $1,189,107
TOTAL EXPENSES $3,509,776

Year-over-Year Comparison

2023 2022 Change
Revenue $4,376,048 $2,114,864 +1.1%
Expenses $3,509,776 $3,470,177 +0.0%
Net Income $866,272 $-1,355,313 -1.6%
Key Indicators
Grants to Organizations Grants to Individuals Lobbying Political Activity Foreign Activities Donor Advised Fund Schedule B Required
🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Sign In

Governance

Voting Members
9
Independent Members
9
Employees
23
Volunteers
9

Governance Policies

Conflict of Interest Policy
Whistleblower Policy
Document Retention Policy

Special Practices & Reported Activities

Operated a School
Operated a Hospital
Provided First Class Travel
Reported Conflict of Interest
Reported Asset Diversion
Excess Benefit Transaction
Made Political Expenditures
Engaged in Lobbying
Operated Donor Advised Fund
Maintained Art Collections
Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers
7
$946,631
Total Directors
9
$0
Key Employees
0
$0
Highest Compensated
5
reported
Name Title Hours/Week Role Reportable Comp Other Comp Total
LISA SERWIN DIRECTOR/VICE CHAIR & SECRETARY 10.00
Officer Director
$0 $0 $0
JANE WILLIAMS MD DIRECTOR/TREASURER 2.00
Officer Director
$0 $0 $0
NEIL RASMUSSEN DIRECTOR/BOARD CHAIR 2.00
Officer Director
$0 $0 $0
ERIC ALM PHD DIRECTOR 2.00
Director
$0 $0 $0
JAMES BILDNER DIRECTOR 2.00
Director
$0 $0 $0
STEPHEN JONES DIRECTOR 2.00
Director
$0 $0 $0
JOANNE KAMENS PHD DIRECTOR 2.00
Director
$0 $0 $0
RUCHIKA KUMAR DIRECTOR 2.00
Director
$0 $0 $0
GARABET YERETSSIAN PHD DIRECTOR 2.00
Director
$0 $0 $0
PAUL LEECH CHIEF OPERATING OFFICER 40.00
Officer
$209,107 $16,008 $225,115
KEN LINDE CHIEF INFORMATION OFFICER 40.00
Officer
$197,254 $37,650 $234,904
MAJDI OSMAN MD MPH CHIEF MEDICAL OFFICER 40.00
Officer
$200,484 $16,342 $216,826
JULIE O'BRIEN CHIEF EXECUTIVE OFFICER 40.00
Officer
$231,693 $38,093 $269,786
SUSAN WEIR SENIOR SCIENTIST 40.00
Highest
$137,216 $4,162 $141,378
KATYA MONIZ DIR OF GLOBAL MICROBIOME CONSERVANCY 40.00
Highest
$153,158 $14,496 $167,654
MICHAEL BOUGAS CLINICAL OUTREACH DIRECTOR 40.00
Highest
$135,000 $24,366 $159,366
DAVE MCCALL HUMAN RESOURCES DIRECTOR 40.00
Highest
$141,570 $35,595 $177,165
SHEVON WALKER DIR OF CMC & SUPPLY CHAIN LOGISTICS 40.00
Highest
$150,338 $37,246 $187,584
Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year Revenue Expenses Assets Net Income
2024 No data No data No data No data
2023 $4,376,048 $3,509,776 $9,964,560 $866,272
2022 $2,114,864 $3,470,177 $9,439,432 $-1,355,313
2021 $6,330,530 $3,245,836 $10,887,542 $3,084,694
2020 $4,240,854 $5,189,003 $8,257,492 $-948,149
2019 $10,542,189 $6,108,448 $11,344,766 $4,433,741
2018 $4,242,867 $4,117,278 $4,089,233 $125,589
Explore More Nonprofits
Top 100 Nonprofits in Massachusetts Largest U.S. Nonprofits Best Rated Nonprofits Most Efficient Nonprofits

Compare MICROBIOME HEALTH RESEARCH INSTITUTE INC with other nonprofits in Massachusetts and across the country.